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Sirs: Epstein Barr-virus (EBV)
exhibits strong B-cell tropism. In
chronic EBV-infection, T-cells may
also be affected, which often
expand monoclonally and then
may progress into T-cell lymphoma
[2, 3]. We describe a young female
with EBV-associated T-cell
clonopathy presenting twice with
monoclonal infiltration of cranial
and spinal nerve roots, which have
not converged into lymphoma by
now after seven years.
In 1997, the 20-year-old patient
developed fever (≤ 40°C), fatigue,
hepatosplenomegaly and mild
lymphadenopathy with pancytope-
nia (Hb 8.3 g/dl, platelets 80000/µl,
neutrophils 500/µl), mildly elevated
CRP (26 mg/l), increased gamma-
globulins (22 g/l), thymidin-kinase
(59.2 U/l), soluble interleukin-2
receptor (sIL-2r) (10696 U/ml) and
neopterin (56.9ng/ml). A macro-
phage activation syndrome (char-
acterized by elevated sIL-2r and
neopterin) was suspected and a
bone-marrow biopsy performed,
revealing massive hemophagocy-
tosis. The patient was splenec-
tomized. Southern blots revealed
monoclonal TCRβ-rearrangement
with singular restriction bands
identical in bone-marrow, blood
and spleen, PCR singular TCRγ-
amplifications identical in blood
and spleen. Based on pediatric
treatment schemes, aiming at
macrophage inhibition, low-dose
VP16-chemotherapy (2 150 mg/
m2) was initiated. Fever and in-
flammation markers declined.
Five weeks later, the patient
developed fever, ear-pain and
diplopia. Clinical examination
revealed a mild meningism and
right abducens nerve palsy. Three
lumbal punctures showed mild
pleocytosis (75/µl, reactive T-cells)
and elevated protein (1.63 g/l).
Blood EBV-VCA IgG/IgM and EBV-
EBNA IgG titres were increased.
Cranial MRI exhibited meningeal
contrast-enhancement along
cranial nerves suggestive of lym-
phomatous meningitis. Intrathecal
chemotherapy with methotrexate
(9 15 mg) and AraC (9 40 mg)
was started, followed by dexam-
ethasone. CSF cell-counts de-
creased to 2/µl, CSF protein to
0.49 g/l. Clinical symptoms and
neurological abnormalities disap-
peared.
In 2002, hyposmia, hypoacusis
and mild urinary disturbances
were noted by the patient, followed
by dizziness and gait disturbances
three months later. On clinical
examination, bilateral L3-S1
deficits with areflexia and positive
Lasegue’s sign were found. Blood
examinations showed normal cell-
counts and CRP, reduced gamma-
globulins (1.5 g/l), increased sIL-2r
(1359IU/ml) and neopterin (3.5 ng/
ml), normal cyclin-D1 and positive
EBV-PCR (125 DNA copies/ml). A
mild CSF pleocytosis (36 cells/µl,
reactive T-cells) with elevated CSF
protein (2.6 g/l) and positive CSF
EBV-PCR were found. Both the
blood and CSF still exhibited
monoclonal TCRγ-rearrangement
with identical clones as six years
before. MRI revealed contrast-
enhancement with dural broaden-
ing around cranial and spinal
nerve roots (Figure). In the absence
of lymphoma cells in three lumbar
puncture specimens, dexametha-
sone (4 8 mg) and intravenous
immunoglobins (3 30 g) were
started. Clinical symptoms rapidly
improved. Today, fourteen months
later, the polyradicular deficits
have normalized. The patient
complains about mild dizziness
and (sensory) hearing difficulties.
In our patient, the recurrent
cranial and spinal nerve root in-
filtrations reflect a steroid-respon-
sive, EBV-related lymphoprolifera-
tive disorder. The absence of
malignant cells in the blood and
CSF, the negative tumour markers
and clinical course allow the exclu-
sion of the presence of a T-cell
lymphoma. Neurological complica-
tions sometimes occur in acute and
reactivated EBV, but rarely in
chronic active EBV-infection [1].
Three patients with chronic active
EBV-infection and encephalitis
have been reported [1, 4, 5]. Two
patients had fatal outcomes, all
three patients exhibited brain
parenchymal involvement on MRI.
Thus, this is the first report of iso-
lated meningoradicular infiltration
in chronic active EBV-infection. In
our patient, a gammaglobulin
deficiency was detected during the
second disease manifestation,
whereas the first episode developed
shortly after chemotherapy. Thus,
immunodeficiency may have
played a pathogenic role.
Monoclonal T-cell expansion
following chronic EBV-infection is
widely regarded as a guaranteed
prelude to malignant lymphoma. In
most cases, this is indeed clearly
the case, although our patient
shows that long-term survival is
possible in a subset of patients. At
present, our patient’s long term
prognosis remains unknown. In
conclusion, meningeal monoclonal
T-cell infiltration in the presence of
chronic active EBV-infection
should not mislead one to the
diagnosis of T-cell lymphoma,
unless a cytological diagnosis is
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made. Clinical manifestations may
well respond to steroids, allowing
the avoidance of chemotherapy.
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Fig. Gadolinium-enhanced T1-weighted MRI showing massive meningeal contrast enhancement (flashes) along cranial (A) and lumbar spinal (B) nerve roots
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